Ypsomed Holding AG (XSWX:YPSN) Dividends Received


XSWX:YPSN Ypsomed Holding AG XSWX:YPSN
92 GF Score
Price CHF361.60
GF Value CHF396.82
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

XSWX:YPSN
92GF Score
Ypsomed Holding AG XSWX:YPSN
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF361.60 is trading 8.9% below its estimated GF Value™ of CHF396.82. GuruFocus considers Ypsomed Holding AG to be Fairly Valued.

Key valuation signals for XSWX:YPSN:

  • Dividends Received:
  • GF Value™: CHF396.82 vs. price of CHF361.60 (8.9% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Other Exchanges YPSNz:UK0QLQ:UKOWX:Germany
Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
92GF Score

Get the complete analysis for XSWX:YPSN

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF361.60
Price
CHF396.82
GF Value